AI-generated content for informational purposes only. Not financial advice. Always do your own research.

Acerca de

Corteva Agriscience (NYSE: CTVA) es una empresa de agricultura de enfoque puro y uno de los proveedores líderes mundiales de semillas y productos de protección de cosechas, escindida de DowDuPont en 2019 para enfocarse exclusivamente en el avance de la productividad agrícola. El segmento de semillas de la empresa ofrece una amplia cartera de germoplasma y características en maíz, soja y otros cultivos bajo las marcas Pioneer y Brevant, mientras su segmento de protección de cosechas proporciona herbicidas, insecticidas y fungicidas a agricultores a nivel mundial. El enfoque dedicado de Corteva en innovación agrícola, incluyendo herramientas de agricultura digital y soluciones biológicas de cosechas, la posiciona como una inversión directa en el futuro de la producción de alimentos y prácticas agrícolas sostenibles.

Acciones de Agricultura

Corteva Agriscience es una empresa agrícola pura enfocada en genética de semillas y productos de protección de cultivos, ofreciendo a los inversores exposición directa a la innovación a nivel de granja incluyendo germoplasma avanzado, tecnologías de rasgos y soluciones de agricultura sostenible.

Acciones de AgriTech

Corteva es una empresa agrícola pura y proveedor global líder de productos de semillas y protección de cultivos, escindida de DowDuPont para enfocarse en la innovación y productividad agrícola.

Key Financials CTVA

Precio $75.03
Cambio (1D) +1.24%
Cambio (30D) +11.93%
Cambio (60D) +17.45%
Cambio (90D) +16.69%
Cambio (180D) +6.70%
Cambio (1Y) +20.90%
Cambio (5Y) +72.76%
P/E Ratio 24.36
EPS (TTM) $3.08
Rango de 52 semanas $53.40 — $77.41
MA de 50 días $69.55
Volumen 3.50M

Data updated Feb 15 · Source: Twelve Data

4.5
2 reviews
Performance
4.5
Fundamentals
4.4
Management Quality
4.4
Risk Profile
4
Valuation
3.8
Claude Opus 4.6
AI Review
4.4/5

Corteva Agriscience, spun off from DowDuPont in 2019, stands as one of the world's leading pure-play agricultural companies with dominant positions in both crop protection and seed technologies. The stock has shown strong momentum, trading near its 52-week high of $77.41 with a 20.9% gain over the past year and impressive 72.8% appreciation over five years.

The bull case centers on Corteva's robust R&D pipeline in biologicals, gene editing, and crop protection innovation, along with pricing power driven by global food security demands. Its dual seed/crop protection platform provides diversification within agriculture. EPS of $3.08 reflects solid profitability, and management has been disciplined with share buybacks.

The bear case includes a P/E of 24.36, which is elevated relative to agricultural peers, suggesting the stock prices in considerable growth expectations. Cyclical exposure to commodity prices, weather variability, and farmer purchasing decisions creates earnings volatility. Regulatory headwinds on certain chemistries and competitive pressure from generics remain ongoing risks.

Overall, Corteva represents a high-quality agricultural franchise with strong innovation credentials, though current valuation demands continued execution on growth initiatives.

Performance
4.5
Fundamentals
4.4
Management Quality
4.4
Risk Profile
4
Valuation
3.8
Feb 15, 2026
Gemini 3 Pro Preview
AI Review
4.6/5

Corteva Agriscience stands out as a premier pure-play vehicle for investors seeking exposure to the global agriculture sector. Commanding a formidable position in both seed technology and crop protection, the company benefits directly from the secular trend of increasing global food demand and the need for yield enhancement. With the stock trading near its 52-week high of $77.41 and sitting comfortably above its 50-day moving average, market sentiment remains bullish. The current P/E ratio of 24.1x reflects a premium valuation, justified by its specialized focus and robust R&D pipeline compared to more diversified competitors. However, investors should remain mindful of the cyclical nature of the agricultural economy, where fluctuations in commodity prices can impact farmer spending power. Despite these risks, Corteva's solid earnings performance and strategic operational efficiencies make it a compelling, albeit fully valued, core holding for long-term agricultural portfolios.

Feb 11, 2026
Corteva Agriscience Screenshot

Added: Feb 10, 2026

corteva.com

Latest from Otrai

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

A stock index is a single number that summarizes the price action of a basket of companies. The S&P 500 tracks roughly 500 large US firms, the Nasdaq-100 tracks the 100 largest non-financial names on the Nasdaq exchange, and the Dow Jones Industrial Average follows 30 blue-chip stocks.

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Greeks explain why an option costs what it costs and how that price changes when the stock moves, time passes, and volatility shifts. Delta, Gamma, Theta, and Vega, made accessible.

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart patterns are the most recognizable part of technical analysis and the most misunderstood. Most fail or break out the wrong way before reversing. This guide covers head and shoulders, double tops and bottoms, triangles, and flags — with realistic reliability, target measurement, and false-breakout confirmation.

Cómo hacer backtest de una estrategia de trading: métodos, errores y qué significan realmente los resultados

Cómo hacer backtest de una estrategia de trading: métodos, errores y qué significan realmente los resultados

Cada trader tiene una estrategia que se ve genial en su cabeza. El backtesting es cómo descubres si realmente funciona. Aquí hay cómo probar estrategias correctamente, qué métricas importan y por qué la mayoría de los resultados de backtest son demasiado buenos para ser verdad.